Amy Herr's most recent trade in Bio-Techne Corp was a trade of 2,735 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Aug. 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bio-Techne | Amy Herr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2025 | 2,735 | 2,735 | - | - | Stock Option (Right to Buy) | |
| Bio-Techne | Amy Herr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2025 | 932 | 932 | - | - | Restricted Stock Units | |
| Bio-Techne | Amy Herr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2025 | 279 | 2,255 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne | Amy Herr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2025 | 160 | 320 | - | - | Restricted Stock Units | |
| Bio-Techne | Amy Herr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2025 | 119 | 118 | - | - | Restricted Stock Units | |
| Bio-Techne | Amy Herr | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.60 per share. | 15 Aug 2025 | 101 | 2,154 (0%) | 0% | 53.6 | 5,414 | Common Stock |
| Bio-Techne | Amy Herr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 1,280 | 0 | - | - | Stock Option (Right to Buy) | |
| Bio-Techne | Amy Herr | Director | Sale of securities on an exchange or to another person at price $ 49.77 per share. | 09 Jun 2025 | 1,280 | 1,976 (0%) | 0% | 49.8 | 63,705 | Common Stock |
| Bio-Techne | Amy Herr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 44.33 per share. | 09 Jun 2025 | 1,280 | 3,256 (0%) | 0% | 44.3 | 56,742 | Common Stock |
| Bio-Techne | Amy Herr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 1,976 | 1,280 | - | - | Stock Option (Right to Buy) | |
| Bio-Techne | Amy Herr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 44.33 per share. | 14 Feb 2025 | 1,976 | 3,836 (0%) | 0% | 44.3 | 87,596 | Common Stock |
| Bio-Techne | Amy Herr | Director | Sale of securities on an exchange or to another person at price $ 65.96 per share. | 14 Feb 2025 | 1,860 | 1,976 (0%) | 0% | 66.0 | 122,691 | Common Stock |
| Bio-Techne | Amy Herr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 2,415 | 2,415 | - | - | Stock Option (Right to Buy) | |
| Bio-Techne | Amy Herr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 1,040 | 1,040 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne | Amy Herr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 344 | 344 | - | - | Stock Option (Right to Buy) | |
| Bio-Techne | Amy Herr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 115 | 115 | - | - | Restricted Stock Units |